Cargando…

MHC Class 1 and PDL-1 Status of Primary Tumor and Lymph Node Metastatic Tumor Tissue in Gastric Cancers

The prognosis of metastatic gastric cancer is poor. Despite the use of VEGF-, EGFR-, and HER2-targeting agents, prognosis is still poor in advanced gastric cancer. Although cancer immunotherapy responds well in some patients, clinical use is limited due to unanswered patients. For this reason, it is...

Descripción completa

Detalles Bibliográficos
Autor principal:	Erdogdu, Ibrahim Halil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381579/ https://www.ncbi.nlm.nih.gov/pubmed/30881447 http://dx.doi.org/10.1155/2019/4785098

Ejemplares similares

Nuclear Factor Kappa B, Matrix Metalloproteinase-1, p53, and Ki-67 Expressions in the Primary Tumors and the Lymph Node Metastases of Colorectal Cancer Cases
por: Meteoglu, Ibrahim, et al.
Publicado: (2015)

Expression of PD1/PDL1 in gastric cancer at different microsatellite status and its correlation with infiltrating immune cells in the tumor microenvironment
por: Wang, Yan-li, et al.
Publicado: (2021)

Pharmacological tumor PDL1 depletion with chlorambucil treats ovarian cancer and melanoma: improves antitumor immunity and renders anti-PDL1-resistant tumors anti-PDL1-sensitive through NK cell effects
por: Bai, Haiyan, et al.
Publicado: (2023)

Integrating No.3 lymph nodes and primary tumor radiomics to predict lymph node metastasis in T1-2 gastric cancer
por: Wang, Xiaoxiao, et al.
Publicado: (2021)

Metastatic lymph nodes and prognosis assessed by the number of retrieved lymph nodes in gastric cancer
por: Wang, Hao, et al.
Publicado: (2022)

Investigation of the Presence of Integrin Alpha-3 and Beta-1 Receptors on Tumor Tissue, Metastatic Lymph Node and Normal Tissue in Thyroid Cancer
por: Arslan, Esra, et al.
Publicado: (2022)

Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors
por: Lei, Qingyang, et al.
Publicado: (2020)

Clinical significance of accurate identification of lymph node status in distant metastatic gastric cancer
por: Zhou, Rui, et al.
Publicado: (2015)

Lymph node stromal cells constrain immunity via MHC class II self-antigen presentation
por: Baptista, Antonio P, et al.
Publicado: (2014)

Molecular signatures of lymph node status by intrinsic subtype: gene expression analysis of primary breast tumors from patients with and without metastatic lymph nodes
por: Shriver, Craig D, et al.
Publicado: (2014)

Comparison of ALK status between primary and corresponding lymph node metastatic tumors in lung cancer patients
por: Gao, Qiqi, et al.
Publicado: (2017)

Transition of tumor-associated macrophages from MHC class II(hi )to MHC class II(low )mediates tumor progression in mice
por: Wang, Benfan, et al.
Publicado: (2011)

DETECTION OF OCCULT LYMPH NODE TUMOR CELLS IN NODE-NEGATIVE GASTRIC CANCER PATIENTS
por: PEREIRA, Marina Alessandra, et al.
Publicado: (2017)

Tumor-Associated Lymphatic Vessels Upregulate PDL1 to Inhibit T-Cell Activation
por: Dieterich, Lothar C., et al.
Publicado: (2017)

What role does PDL1 play in EMT changes in tumors and fibrosis?
por: Zhang, Yun-Chao, et al.
Publicado: (2023)

Clinical implications of metastatic lymph node ratio in gastric cancer
por: Liu, Caigang, et al.
Publicado: (2007)

The Prognostic Value of Harvested Lymph Nodes and the Metastatic Lymph Node Ratio for Gastric Cancer Patients: Results of a Study of 1,101 Patients
por: Chen, Shi, et al.
Publicado: (2012)

Current status of lymph node micrometastasis in gastric cancer
por: Zhou, Yang, et al.
Publicado: (2017)

Current status of lymph node dissection in gastric cancer
por: Ke, Bin, et al.
Publicado: (2021)

Evidence of pseudoprogression in patients treated with PD1/PDL1 antibodies across tumor types
por: Martin‐Romano, Patricia, et al.
Publicado: (2020)

Impact of Tumor Site on Lymph Node Status and Survival in Colon Cancer
por: Xie, Yayun, et al.
Publicado: (2019)

Pathological tumor regression grade of metastatic tumors in lymph node predicts prognosis in esophageal cancer patients
por: Kadota, Tomohiro, et al.
Publicado: (2018)

Cystic trophoblastic tumor – The effect of chemotherapy in metastatic testicular germ cell tumor to retroperitoneal lymph nodes
por: Narla, Swetha, et al.
Publicado: (2020)

PD-1/PD-L1 Blockade Therapy for Tumors with Downregulated MHC Class I Expression
por: Šmahel, Michal
Publicado: (2017)

Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinuses
por: Das, Suvendu, et al.
Publicado: (2013)

Sex-Associated Expression of Co-Stimulatory Molecules CD80, CD86, and Accessory Molecules, PDL-1, PDL-2 and MHC-II, in F480+ Macrophages during Murine Cysticercosis
por: Togno-Peirce, Cristián, et al.
Publicado: (2013)

Lymph node status as a prognostic factor after palliative resection of primary tumor for patients with metastatic colorectal cancer
por: Li, Qingguo, et al.
Publicado: (2017)

MACC1 regulates PDL1 expression and tumor immunity through the c‐Met/AKT/mTOR pathway in gastric cancer cells
por: Tong, Gangling, et al.
Publicado: (2019)

Draining Lymph Nodes of Corneal Transplant Hosts Exhibit Evidence for Donor Major Histocompatibility Complex (MHC) Class II–positive Dendritic Cells Derived from MHC Class II–negative Grafts
por: Liu, Ying, et al.
Publicado: (2002)

Synchronous Peripancreatic Lymph Node Gastrinoma and Gastric Neuroendocrine Tumor Type 2
por: Lee, Hee Woo, et al.
Publicado: (2016)

Metastatic lymph node in gastric cancer; Is it a real distant metastasis?
por: Lim, Do Hyoung, et al.
Publicado: (2010)

Poor Prognosis of Advanced Gastric Cancer with Metastatic Suprapancreatic Lymph Nodes
por: Kusano, Toru, et al.
Publicado: (2013)

Predictors of Metastatic Lymph Nodes at Preoperative Staging CT in Gastric Adenocarcinoma
por: Crimì, Filippo, et al.
Publicado: (2022)

Immunotherapy for Soft Tissue Sarcomas: Anti-PD1/PDL1 and Beyond
por: Fazel, Mina, et al.
Publicado: (2023)

Identification of PDL1-Related Biomarkers to Select Lung Adenocarcinoma Patients for PD1/PDL1 Inhibitors
por: Wu, Yanping, et al.
Publicado: (2020)

Should the left gastric artery lymph node be considered as the predictive lymph node for extra-gastric lymph node metastases?
por: Sun, Weilin, et al.
Publicado: (2020)

Identification and Validation of a PD-L1 Binding Peptide for Determination of PDL1 Expression in Tumors
por: Caldwell, Charles, et al.
Publicado: (2017)

Interferon beta 1, an intermediate in the tumor necrosis factor alpha- induced increased MHC class I expression and an autocrine regulator of the constitutive MHC class I expression
Publicado: (1987)

Co-localization of CD169(+) macrophages and cancer cells in lymph node metastases of breast cancer patients is linked to improved prognosis and PDL1 expression
por: Björk Gunnarsdottir, Frida, et al.
Publicado: (2020)

Current Status and Scope of Lymph Node Micrometastasis in Gastric Cancer
por: Lee, Chang Min, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_nodgfn2otl6a83fmasjq52qkr1